22 results
8-K
EX-99.2
EDIT
Editas Medicine, Inc.
14 Jun 24
All patients treated in the RUBY trial are free of vaso-occlusive events post-renizgamglogene autogedtemcel (reni-cel) infusion
6:04am
, with total Hb rising above the transfusion independence threshold of 9.0 g/dL. For patients with ≥6 months follow-up, the mean (standard deviation; SD) total
8-K
EDIT
Editas Medicine, Inc.
14 Jun 24
All patients treated in the RUBY trial are free of vaso-occlusive events post-renizgamglogene autogedtemcel (reni-cel) infusion
6:04am
trial, patients demonstrated early and robust total Hb and HbF increases, with total Hb rising above the transfusion independence threshold of 9.0 g
8-K
1r7wj3aj03
11 Dec 23
Regulation FD Disclosure
4:23pm
8-K
EX-99.1
cimbr
11 Dec 23
Regulation FD Disclosure
4:23pm
DEFA14A
ene1dug 0pcp9
21 May 21
Additional proxy soliciting materials
6:03am
10-K
8mzn3c
30 Mar 16
Annual report
12:00am